In personalized medicine for the treatment of neoplasms, the recent paradigm has been based on identifying specific molecular alterations which allow predicting sensitivity to targeted therapies (target therapies) or immunotherapy. The most accredited pathogenetic model predicts that tumors are generated, progressed, and spread in the body by accumulating genetic mutations.
SAVE THE DATE: "Mogliano Veneto Seminar" - Edition 7 - Mogliano Veneto, September 26th and 27th 2024
